Mounjaro®
Starting from £179.99/mo
Start journey Learn moreThe short answer: the specific hour is less important than keeping that hour the same every week. Wegovy (semaglutide) stays active in your body for around seven days, so a consistent weekly rhythm matters far more than whether you inject at 8am or 8pm. That said, the time you choose can influence how manageable the side effects feel day to day. These are prescription-only medicines and a clinician reviews your full picture before prescribing — but the timing question is one worth thinking through carefully before you settle on a routine.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Picture this: it's Friday evening, you've got your Wegovy pen, and you're staring at the instruction leaflet wondering whether morning or night makes a difference. You're not alone, it's one of the questions our prescribers hear regularly.
Semaglutide, the active ingredient in Wegovy, has a half-life of roughly seven days, meaning levels in your body rise and fall slowly over the whole week rather than spiking and dropping within hours. Wegovy's pharmacology is quite different from a daily tablet in this respect. Because the drug persists for so long, injecting at 9am versus 9pm on the same day produces no clinically meaningful difference in how much semaglutide is available in your system.
What does matter is consistency. If you inject on a Tuesday morning this week, Tuesday morning next week is the target. Drifting by an hour or two is fine; the semaglutide patient information on the NHS confirms you can take it any time of day, with or without food. Shifting your day by more than a couple of days is worth discussing with your prescriber first.
So the practical advice is: choose a time that genuinely suits your life, then protect it.
The most common reason people opt for an evening injection is nausea. During the early weeks at 0.25mg or after a dose increase, some people feel queasy for a few hours after the injection. Sleeping through that window is a legitimate strategy, and many find it reduces how disruptive the side effects feel day to day.
There's no clinical trial data directly comparing morning versus evening timing for nausea severity, the large STEP 1 trial, published in the New England Journal of Medicine, recorded the rate of gastrointestinal side effects across the study but didn't stratify by injection time. So this remains practical experience rather than controlled evidence.
What the data does show is that GI effects (nausea, mild indigestion, occasional loose stools) are most noticeable in the first few weeks and after dose increases, then settle for most people. Choosing an evening time because it eases that adjustment phase is sensible self-management. If nausea remains troublesome regardless of timing, talk to your prescriber rather than quietly reducing your dose; adjustments should always be clinician-led.
Some people prefer mornings simply because they're more reliable. Injecting before the school run on a Saturday becomes a habit that sticks. Either works.
Timing and day are connected. The question of which day to choose deserves its own thinking-through, because it feeds into the time question too. Most people pick a day tied to a fixed routine, a weekend morning with fewer competing demands, or a weekday evening when there's no early alarm to follow.
If you do need to shift your usual day, the NHS guidance on Wegovy covers exactly how much flexibility you have: administering on a different day is acceptable provided the gap between doses is at least four days. For anything more nuanced, your prescriber and the Patient Information Leaflet are the right sources, not online forums.
The question of the best time of day for Wegovy is closely related, and we've covered the practicalities in more detail there. If you're weighing up specific scenarios (shift work, travel across time zones, or managing alongside other medicines) those pages go deeper. For questions about what Wegovy costs as a private prescription, our cost guide sets out what a transparent private service should include.
A few situations genuinely warrant a conversation rather than self-troubleshooting. If you're experiencing side effects severe enough that you're considering skipping a dose, tell your clinical team. If you're planning surgery (even day-case procedures) your anaesthetist and surgical team need to know you're on a GLP-1 medicine; the NHS England guidance on weight-management injections specifically flags this because gastric emptying is affected. If you're adding a new regular medicine to your routine, your prescriber should review any potential interactions before you decide how to sequence your weekly Wegovy injection.
The healthcare professional information for Wegovy covers interactions and clinical considerations in detail. And if you have side effects you're unsure about (whether they're new, persistent, or worsening) the right move is to contact your prescribing team or, for anything urgent, seek medical attention directly. The MHRA's Yellow Card scheme also lets you report any suspected side effects from your treatment.
If you're not yet on Wegovy and are exploring whether it might suit you, checking your eligibility is the natural first step. A clinician, not an algorithm, reads your consultation the same day.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.